Compass Oncology Vancouver — Vancouver, Washington

Compass Oncology Vancouver is a clinical research site located in Vancouver, Washington, United States 98684.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Compass Oncology Vancouver has participated in 51 clinical trials with 19 currently active.

Therapeutic areas: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology Vancouver?

Compass Oncology Vancouver has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology Vancouver conducted?

Compass Oncology Vancouver has 51 clinical trials on record, with 19 currently active. Their work covers brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Is Compass Oncology Vancouver accredited by Crixeo Health?

Yes — Compass Oncology Vancouver holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Compass Oncology Vancouver?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.